Global Brand Lead

About the role

The Director, Global Brand Lead (GBL) supports the development of the global commercialization strategy for TAK-279 in psoriasis. This role involves driving the translation of zasocitinib PsA global brand strategy into execution, building the core promotional materials, leading KOL engagement, and ensuring successful launch readiness.

Responsibilities

• Drive translation of zasocitinib PsA global brand strategy into execution
• Contribute to the refinement of the PsA brand strategy and translation of strategic direction into clear positioning, messaging, and brand narrative
• Partner with Insights & Analytics to identify and apply key customer and market insights to strengthen brand positioning and differentiation
• Evolve the brand identity and creative campaign from psoriasis launch to ensure zasocitinib stands out in a competitive PsA market
• Lead the evolution of the global brand plan, incorporating regional/LOC stakeholders to ensure strategic alignment and market relevance
• Build launch promotional materials to enable LOCs to successfully launch zasocitinib in PsA
• Own end-to-end development of core global marketing materials (e.g., messaging platform, campaign assets, brand book, core visual aids), incorporating input from Regions and LOCs
• Lead agency management and execution for development of materials, including briefing, feedback, timelines, and quality control
• Apply customer insights and regional/LOC feedback to ensure materials are differentiated, practical, and ready for market adoption
• Drive KOL engagement and insights integration
• Lead development and execution of the global KOL engagement plan, including ad boards, 1:1 engagements, and congress-related activities
• Collaborate cross-functionally (e.g., Medical, ClinSci) to ensure coordinated and impactful KOL engagement across key congresses
• Translate insights into clear implications for brand strategy, messaging, and materials
• Develop commercial congress assets and speaker materials to support LOC readiness and external engagement, including post-approval launch events
• Drive global launch readiness
• Partner with Launch Excellence to lead launch readiness reviews/exchanges with functions, regions, and LOCs to identify risks, interdependencies, and mitigations
• Support Global Launch Summit(s) to enable LOC preparedness and competitiveness
• Owntimely delivery of launch tools, materials, and guidance to support region/LOC preparedness and competitive readiness

Core elements related to this role

First Global Brand Lead for zasocitinib in Rheumatology, responsible for bridging strategy and execution to enable a successful second-indication launch in PsA. Acts as the central execution engine, translating strategic direction into compelling materials, actionable KOL insights, and launch-ready deliverables. Operates with high independence, driving cross-functional alignment and agency execution. Contributes to ongoing brand evolution and lifecycle management based on early launch learnings and market feedback.

Technical/Functional (Line) Expertise

• Launch Experience Required (global)
• Seasoned marketer with in-line brand experience required (global)
• Knowledge and experience with digital engagement among patients and HCPs
• Business acumen, with a strong appreciation for cross-cultural and cross-functional differences
• Ability to understand and interpret medical information; working knowledge of evidence-based medicine
• Leadership (Vision, strategy and business alignment, people management, communication, influencing others, managing change)
• Strong organizational skills and managing up and down
• Learning agility, curiosity (aptitude for new technologies)
• Adaptable to and comfortable with change on personal and organizational level
• Demonstrable ability to present to large groups; able to translate complex data into actionable messages
• Listening and understanding skills; ability to comprehend stakeholders' points of view
• Decision-making and Autonomy (The capacity and authority to make organizational decisions, autonomy in decision-making, complexity of decisions, impact of decisions, problem-solving)
• Accountability and ownership; able to take calculated risk and allow others to take initiative
• Collaborative problem-solver, confident to share his/her ideas with all levels of management
• Sufficient judgment and decision-making skills, with demonstrated evidence-based approaches
• Able to challenge appropriately the status quo and provide alternative solutions
• Team player, creating atmosphere of trust; helping others to learn and grow; actively seeking feedback
• Innovation (The required level of scientific knowledge, knowledge sharing, innovation and risk taking)
• Energy and drive – entrepreneurial spirit
• Sufficient understanding of medical science to interpret data and to draw conclusions; working knowledge of evidence-based medicine
• Complexity (Products managed, mix of businesses, internal and/or external business environment, cultural considerations)
• High complexity: ability to juggle multiple priorities and successfully launch into a very competitive and established market
• Ability to think outside the box
• Working across cultures – recognizing different business, clinical and legal practices; keeping compliance with Takeda's values and SOP

Education, Behavioral Competencies and Skills

• University degree in marketing/business or life sciences; advanced degree preferred
• 10+ years pharma experience with strong track record in pre-launch / launch execution and global marketing roles
• Experience in rheumatology, dermatology, immunology or close-related specialty areas strongly preferred
• Demonstrated ability to translate strategy into end-to-end execution, including agency management, budget and timeline ownership, and delivery of launch-critical assets
• Excellent communication/influencing skills, with ability to operate effectively across senior, cross-functional, and global stakeholders
• Able to work independently and drive outcomes with minimal direction in a fast-paced, evolving environment

Additional Information

Domestic and international travel 25%